Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 33978 | 118 | 27.9 | 39% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 141 | 3 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS | 64640 |
| 2486 | 2 | PYRAZINAMIDE//ISONIAZID//RIFAMPICIN | 3933 |
| 33978 | 1 | AGROCHEMICAL INTERACTIONS//ATENOLOL METABOLIC ACTIONS//METOPROLOL METABOLIC ACTIONS | 118 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | AGROCHEMICAL INTERACTIONS | authKW | 258776 | 1% | 100% | 1 |
| 2 | ATENOLOL METABOLIC ACTIONS | authKW | 258776 | 1% | 100% | 1 |
| 3 | METOPROLOL METABOLIC ACTIONS | authKW | 258776 | 1% | 100% | 1 |
| 4 | PENICILLIN MICROINJECTION | authKW | 258776 | 1% | 100% | 1 |
| 5 | RIFAMPICINE DRUG INTERACTION | authKW | 258776 | 1% | 100% | 1 |
| 6 | RAT LIVER MONOOXYGENASES | authKW | 86257 | 1% | 33% | 1 |
| 7 | THEOPHYLLINE PHARMACOKINETICS | authKW | 86257 | 1% | 33% | 1 |
| 8 | CAS 37350 58 6 | authKW | 51754 | 1% | 20% | 1 |
| 9 | CAS 29122 68 7 | authKW | 36966 | 1% | 14% | 1 |
| 10 | TUBERCULOSIS CHEST UNIT | address | 32345 | 1% | 13% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Medicine, General & Internal | 800 | 38% | 0% | 45 |
| 2 | Pharmacology & Pharmacy | 417 | 36% | 0% | 42 |
| 3 | Respiratory System | 35 | 5% | 0% | 6 |
| 4 | Infectious Diseases | 25 | 5% | 0% | 6 |
| 5 | Chemistry, Medicinal | 9 | 3% | 0% | 4 |
| 6 | Toxicology | 9 | 3% | 0% | 4 |
| 7 | Microbiology | 9 | 5% | 0% | 6 |
| 8 | Parasitiology | 6 | 2% | 0% | 2 |
| 9 | Virology | 3 | 2% | 0% | 2 |
| 10 | Public, Environmental & Occupational Health | 3 | 3% | 0% | 4 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | TUBERCULOSIS CHEST UNIT | 32345 | 1% | 13% | 1 |
| 2 | CLIN PHARM PRACTICE SECT | 21563 | 1% | 8% | 1 |
| 3 | METHODIST UNIV HOSP | 8624 | 1% | 3% | 1 |
| 4 | NEW JERSEY AGR EXPT STN | 1557 | 1% | 1% | 1 |
| 5 | PHARMACEUT SCI HIGASHI KU | 1305 | 1% | 1% | 1 |
| 6 | DRUG TOXICOL | 1123 | 1% | 0% | 1 |
| 7 | GEN PATHOL PATHOPHYSIOL | 484 | 1% | 0% | 1 |
| 8 | FARM TECNOL FARMACEUT | 316 | 1% | 0% | 1 |
| 9 | PHARMACOTHER Y | 278 | 1% | 0% | 1 |
| 10 | COOK | 257 | 1% | 0% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS | 12811 | 3% | 1% | 4 |
| 2 | THERAPEUTISCHE UMSCHAU | 7317 | 4% | 1% | 5 |
| 3 | WHO CHRONICLE | 4041 | 1% | 2% | 1 |
| 4 | MUNCHENER MEDIZINISCHE WOCHENSCHRIFT | 3976 | 4% | 0% | 5 |
| 5 | SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT | 3459 | 8% | 0% | 9 |
| 6 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 3252 | 6% | 0% | 7 |
| 7 | ACTA MICROBIOLOGICA HUNGARICA | 2521 | 2% | 0% | 2 |
| 8 | TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH | 2394 | 1% | 1% | 1 |
| 9 | CHEMOTHERAPY | 1629 | 3% | 0% | 4 |
| 10 | BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE | 1321 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LEE, CR , THRASHER, KA , (2001) DIFFICULTIES IN ANTICOAGULATION MANAGEMENT DURING COADMINISTRATION OF WARFARIN AND RIFAMPIN.PHARMACOTHERAPY. VOL. 21. ISSUE 10. P. 1240 -1246 | 6 | 60% | 16 |
| 2 | KRAJEWSKI, KC , (2010) INABILITY TO ACHIEVE A THERAPEUTIC INR VALUE WHILE ON CONCURRENT WARFARIN AND RIFAMPIN.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 50. ISSUE 6. P. 710-713 | 5 | 56% | 5 |
| 3 | FAHMI, AM , ABDELSAMAD, O , ELEWA, H , (2016) RIFAMPIN-WARFARIN INTERACTION IN A MITRAL VALVE REPLACEMENT PATIENT RECEIVING RIFAMPIN FOR INFECTIVE ENDOCARDITIS: A CASE REPORT.SPRINGERPLUS. VOL. 5. ISSUE . P. - | 6 | 33% | 0 |
| 4 | YEW, WW , (2002) CLINICALLY SIGNIFICANT INTERACTIONS WITH DRUGS USED IN THE TREATMENT OF TUBERCULOSIS.DRUG SAFETY. VOL. 25. ISSUE 2. P. 111 -133 | 23 | 12% | 46 |
| 5 | MARTINS, MAP , REIS, AMM , SALES, MF , NOBRE, V , RIBEIRO, DD , ROCHA, MOC , RIBEIRO, ALP , (2013) RIFAMPICIN-WARFARIN INTERACTION LEADING TO MACROSCOPIC HEMATURIA: A CASE REPORT AND REVIEW OF THE LITERATURE.BMC PHARMACOLOGY & TOXICOLOGY. VOL. 14. ISSUE . P. - | 6 | 32% | 3 |
| 6 | TORRENT, J , IZQUIERDO, I , CABEZAS, R , JANE, F , (1989) THEOPHYLLINE-ISONIAZID INTERACTION.DICP-THE ANNALS OF PHARMACOTHERAPY. VOL. 23. ISSUE 2. P. 143-145 | 4 | 100% | 8 |
| 7 | SAMIGUN , MULYONO , SANTOSO, B , (1990) LOWERING OF THEOPHYLLINE CLEARANCE BY ISONIAZID IN SLOW AND RAPID ACETYLATORS.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 29. ISSUE 5. P. 570-573 | 5 | 71% | 0 |
| 8 | CASNER, PR , (1996) INABILITY TO ATTAIN ORAL ANTICOAGULATION: WARFARIN-RIFAMPIN INTERACTION REVISITED.SOUTHERN MEDICAL JOURNAL. VOL. 89. ISSUE 12. P. 1200-1203 | 4 | 67% | 4 |
| 9 | MALHI, R , UPPAL, R , SHARMA, PL , (1992) DRUG-INTERACTION BETWEEN RIFAMPICIN, ISONIAZID AND COTRIMOXAZOLE IN RABBITS.HUMAN & EXPERIMENTAL TOXICOLOGY. VOL. 11. ISSUE 2. P. 105-107 | 3 | 100% | 2 |
| 10 | SELF, T , CORLEY, CR , NABHAN, S , ABELL, T , (1996) CASE REPORT: INTERACTION OF RIFAMPIN AND NORTRIPTYLINE.AMERICAN JOURNAL OF THE MEDICAL SCIENCES. VOL. 311. ISSUE 2. P. 80-81 | 3 | 75% | 11 |
Classes with closest relation at Level 1 |